Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Hematopoietic stem cell transplantation (HCT) is a potentially life-saving treatment that uses healthy blood-forming cells from donors to replace dysfunctional or damaged hematopoietic cells in patients with various blood disorders. This procedure is often employed to treat conditions such as hematological malignancies (e.g., leukemia, lymphoma, myeloma) and other severe blood or immune system diseases. Monitoring post-transplant complications is essential for tracking physiological effects and aiding in clinical decision-making. Biobehavioral aspects of care partners (i.e., unpaid caregivers) can also be influenced during the post-transplant stage of HCT. Wearable devices offer a non-invasive way to continuously track physiological parameters, making them a valuable resource for health monitoring. However, the physiological data collected from wearables is highly unstructured, often containing missing values, outliers, redundant features, and erroneous measurements leading to false conclusions/prediction. Therefore, enhancing data quality is essential for deriving meaningful insights. This paper introduces novel pre-processing methods to build a high quality, comprehensive, standardized, AI/ML ready, and clinically meaningful wearable dataset of HCT patients and caregivers. To test our data cleaning implementation, our cleaned, high-quality dataset is utilized to predict mood and compliance in HCT patients and their caregivers using machine learning algorithms. The paper illustrates our proposed approach and presents experimental results conducted on the data collected from Michigan Medicine for HCT patients and caregivers. Our preliminary experimental results are promising, demonstrating the effectiveness of the proposed methods and the high-quality dataset in predicting mood and compliance for the participants.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12316481PMC
http://dx.doi.org/10.1109/bigdata62323.2024.10825132DOI Listing

Publication Analysis

Top Keywords

hct patients
16
patients caregivers
16
mood compliance
12
data collected
8
high-quality dataset
8
hct
6
data
5
patients
5
caregivers
5
preparing wearable
4

Similar Publications

Given the dismal prognosis for patients with TP53-mutated acute myeloid leukemia (AML), the optimal donor for those undergoing allogeneic hematopoietic cell transplantation (allo-HCT) remains unclear. We retrospectively analyzed adult patients with TP53-mutated AML who underwent first allo-HCT in CR1 between 2010 and 2021. Outcomes were compared among using a haploidentical donor (Haplo), a matched sibling donor (MSD), and a 10/10 matched unrelated donor (MUD).

View Article and Find Full Text PDF

Introduction: The impact of race on outcomes of allogeneic hematopoietic cell transplants (HCT) has long been a field of research. The Center for International Blood and Marrow Transplant Research (CIBMTR) studies have shown worse survival for Black and Hispanic patients within the first year after HCT, but rates evened out for one-year survivors. From our personal experience, we hypothesize that the outcomes of South Asians (age ≥ 45 years) receiving myeloablative conditioning (MAC) are also worse compared to other races.

View Article and Find Full Text PDF

Early in the COVID-19 pandemic, screening was initiated in several settings to mitigate asymptomatic transmission of SARS-CoV-2. However, this practice was later discouraged by the Society for Healthcare Epidemiology of America. This single-center retrospective study demonstrates limited utility of SARS-CoV-2 screening tests in asymptomatic HCT and CAR T-cell patients.

View Article and Find Full Text PDF

Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations.

Bone Marrow Transplant

September 2025

Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), University of Barcelona, Barcelona, Spain.

For over two decades, the EBMT has updated recommendations on indications for haematopoietic cell transplantation (HCT) practice based on clinical and scientific developments in the field. This is the ninth special EBMT report on indications for HCT for haematological diseases, solid tumours and immune disorders. Our aim is to provide guidance on HCT indications according to prevailing clinical practice in EBMT countries and centres.

View Article and Find Full Text PDF

Background: Approximately 10-30 % of the youth (aged 15-24) have a diagnosed chronic medical condition. Effective transition from pediatric to adult care is thus essential for disease management. The growing interest in the transition of young people with chronic medical conditions has led to numerous international studies revealing diverse and often inadequate transition practices.

View Article and Find Full Text PDF